Granulocyte colony-stimulating factor treatment ameliorates liver injury and improves survival in rats with d-galactosamine-induced acute liver failure

Toxicology Letters

Volumn 204, Issue 1, 2011, Pages 92-99

  Zhang, Lei ^a   Kang, Wen ^a   Lei, Yan ^a   Han, Qunying ^a   Zhang, Guoyu ^a   Lv, Yi ^a   Li, Zhu ^a   Lou, Sai ^a   Liu, Zhengwen ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute liver failure; Bone marrow mobilization; D Galactosamine; G CSF; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; CD34 ANTIGEN; GALACTOSAMINE; KI 67 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

ACUTE LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RAT; STEM CELL MOBILIZATION; SURVIVAL RATE;

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD34; DRUG-INDUCED LIVER INJURY; FEMALE; FLOW CYTOMETRY; GALACTOSAMINE; GRANULOCYTE COLONY-STIMULATING FACTOR; LIVER; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES;

ANIMALIA; RATTUS;

EID: 79957858196     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.04.016     Document Type: Article

References (51)

1. Adachi Y., Imagawa J., Suzuki Y., Yogo K., Fukazawa M., Kuromaru O., Saito Y. G-CSF treatment increases side population cell infiltration after myocardial infarction in mice. J. Mol. Cell. Cardiol. 2004, 36:707-710.
2. Alison M.R., Poulsom R., Jeffery R., Dhillon A.P., Quaglia A., Jacob J., Novelli M., Prentice G., Williamson J., Wright N.A. Hepatocytes from non-hepatic adult stem cells. Nature 2000, 406:257.
3. Bernuau J., Rueff B., Benhamou J.P. Fulminant and subfulminant liver failure: definitions and causes. Semin. Liver Dis. 1986, 6:97-106.
4. Caraceni P., Giannone F., Catani L., Talarico S., Pertosa A.M., Domenicali M., Fogli M., Principe A., Trevisani F., Baccarani M., Bernardi M., Lemoli R.M. Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. Dig. Liver Dis. 2007, 39:943-951.
5. Di Campli C., Zocco M.A., Saulnier N., Grieco A., Rapaccini G., Addolorato G., Rumi C., Santoliquido A., Leone G., Gasbarrini G., Gasbarrini A. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Dig. Liver Dis. 2007, 39:1071-1076.
6. England T.J., Gibson C.L., Bath P.M. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review. Brain Res. Rev. 2009, 62:71-82.
7. Finney D.J. The median lethal dose and its estimation. Arch. Toxicol. 1985, 56:215-218.
8. Gaia S., Smedile A., Omedè P., Olivero A., Sanavio F., Balzola F., Ottobrelli A., Abate M.L., Marzano A., Rizzetto M., Tarella C. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J. Hepatol. 2006, 45:13-19.
9. Gujral J.S., Farhood A., Jaeschke H. Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats. Toxicol. Appl. Pharmacol. 2003, 190:37-46.
10. Hou X.W., Jiang Y., Wang L.F., Xu H.Y., Lin H.M., He X.Y., He J.J., Zhang S. Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities. Toxicol. Lett. 2009, 187:40-44.
11. Huiling X., Inagaki M., Arikura J., Ozaki A., Onodera K., Ogawa K., Kasai S. Hepatocytes derived from peripheral blood stem cells of granulocyte-colony stimulating factor treated F344 rats in analbuminemic rat livers. J. Surg. Res. 2004, 122:75-82.
12. Ishizawa K., Kubo H., Yamada M., Kobayashi S., Numasaki M., Ueda S., Suzuki T., Sasaki H. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett. 2004, 556:249-252.
13. Iwasaki M., Adachi Y., Minamino K., Suzuki Y., Zhang Y., Okigaki M., Nakano K., Koike Y., Wang J., Mukaide H., Taketani S., Mori Y., Takahashi H., Iwasaka T., Ikehara S. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J. Am. Soc. Nephrol. 2005, 16:658-666.
14. Kanazawa Y., Verma I.M. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(Suppl. 1):11850-11853.
15. Kang W., Liu Z.W., Han Q.Y., Zhang L., Lei Y., Lou S. Effects of granulocyte colony-stimulating factor on hepatocyte apoptosis in acute liver failure: experiment with rats. Zhonghua Yi Xue Za Zhi (Chin. Med. J.) 2008, 88:980-984. (in Chinese).
16. Korbling M., Katz R.L., Khanna A., Ruifrok A.C., Rondon G., Albitar M., Champlin R.E., Estrov Z. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N. Engl. J. Med. 2002, 346:738-746.
17. Krause D.S., Theise N.D., Collector M.I., Henegariu O., Hwang S., Gardner R., Neutzel S., Sharkis S.J. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377.
18. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., Wang X., Finegold M., Weissman I.L., Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6:1229-1234.
19. Lee S.T., Chu K., Jung K.H., Ko S.Y., Kim E.H., Sinn D.I., Lee Y.S., Lo E.H., Kim M., Roh J.K. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 2005, 1058:120-128.
20. Lee W.M. Acute liver failure. N. Engl. J. Med. 1993, 329:1862-1872.
21. Lei Y., Liu Z., Han Q., Kang W., Zhang L., Lou S. G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure. Dig. Dis. Sci. 2010, 55:285-291.
22. Liou I.W., Larson A.M. Role of liver transplantation in acute liver failure. Semin. Liver Dis. 2008, 28:201-209.
23. Liu Q. Role of cytokines in the pathophysiology of acute-on-chronic liver failure. Blood Purif. 2009, 28:331-341.
24. Lorenzini S., Isidori A., Catani L., Gramenzi A., Talarico S., Bonifazi F., Giudice V., Conte R., Baccarani M., Bernardi M., Forbes S.J., Lemoli R.M., Andreone P. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment. Pharmacol. Ther. 2008, 27:932-939.
25. Mehendale H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 2005, 33:41-51.
26. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., Koda M., Arai M., Misao Y., Lu C., Suzuki K., Goto K., Komada A., Takahashi T., Kosai K., Fujiwara T., Fujiwara H. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004, 109:2572-2580.
27. Nishida M., Fujimoto S., Toiyama K., Sato H., Hamaoka K. Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice. Biochem. Biophys. Res. Commun. 2004, 324:341-347.
28. Ogiso T., Nagaki M., Takai S., Tsukada Y., Mukai T., Kimura K., Moriwaki H. Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1beta. J. Hepatol. 2007, 47:816-825.
29. O'Grady J.G., Schalm S.W., Williams R. Acute liver failure: redefining the syndromes. Lancet 1993, 342:273-275.
30. Ohtsuka M., Takano H., Zou Y., Toko H., Akazawa H., Qin Y., Suzuki M., Hasegawa H., Nakaya H., Komuro I. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 2004, 18:851-853.
31. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10344-10349.
32. Petersen B.E., Bowen W.C., Patrene K.D., Mars W.M., Sullivan A.K., Murase N., Boggs S.S., Greenberger J.S., Goff J.P. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168.
33. Piscaglia A.C., Shupe T.D., Oh S.H., Gasbarrini A., Petersen B.E. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007, 133:619-631.
34. Quintana-Bustamante O., Alvarez-Barrientos A., Kofman A.V., Fabregat I., Bueren J.A., Theise N.D., Segovia J.C. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 2006, 43:108-116.
35. Reddy R.L. Mobilization and collection of peripheral blood progenitor cells for transplantation. Transfus. Apher. Sci. 2005, 32:63-72.
36. Riordan S.M., Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin. Liver Dis. 2003, 23:203-215.
37. Rolando N., Clapperton M., Wade J., Panetsos G., Mufti G., Williams R. Granulocyte colony-stimulating factor improves function of neutrophils from patients with acute liver failure. Eur. J. Gastroenterol. Hepatol. 2000, 12:1135-1140.
38. Rolando N., Clapperton M., Wade J., Wendon J. Administering granulocyte colony-stimulating factor to acute liver failure patients corrects neutrophil defects. Eur. J. Gastroenterol. Hepatol. 2000, 12:1323-1328.
39. Rumi C., Rutella S., Teofili L., Etuk B., Ortu La Barbera E., Micciulli G., Voso M.T., Leone G. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression. Exp. Hematol. 1997, 25:246-251.
40. Spahr L., Lambert J.F., Rubbia-Brandt L., Chalandon Y., Frossard J.L., Giostra E., Hadengue A. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008, 48:221-229.
41. Stokman G., Leemans J.C., Claessen N., Weening J.J., Florquin S. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J. Am. Soc. Nephrol. 2005, 16:1684-1692.
42. Stravitz R.T., Kramer A.H., Davern T., Shaikh A.O., Caldwell S.H., Mehta R.L., Blei A.T., Fontana R.J., McGuire B.M., Rossaro L., Smith A.D., Lee W.M., Acute Liver Failure Study Group Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit. Care Med. 2007, 35:2498-2508.
43. Theise N.D., Badve S., Saxena R., Henegariu O., Sell S., Crawford J.M., Krause D.S. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31:235-240.
44. Theocharis S.E., Agapitos E.B., Margeli A.P., Goutas N.D., Kittas C.N., Davaris P.S. Effect of two forms of granulocyte-colony-stimulating factor on hepatic regeneration after 70% partial hepatectomy in rats. Clin. Sci. (Lond.) 1997, 92:315-320.
45. Theocharis S.E., Margeli A.P., Goutas N.D., Horti M.G., Karkantaris C.S., Kittas C.N. Granulocyte colony-stimulating factor administration reverses cadmium-associated inhibition of hepatocyte regeneration. Eur. J. Gastroenterol. Hepatol. 1996, 8:805-809.
46. Theocharis S.E., Margeli A.P., Kittas C.N. Effect of granulocyte colony-stimulating-factor administration on tissue regeneration due to thioacetamide-induced liver injury in rats. Dig. Dis. Sci. 1999, 44:1990-1996.
47. Theocharis S.E., Papadimitriou L.J., Retsou Z.P., Margeli A.P., Ninos S.S., Papadimitriou J.D. Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy. Dig. Dis. Sci. 2003, 48:1797-1803.
48. Thomas J., Liu F., Link D.C. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr. Opin. Hematol. 2002, 9:183-189.
49. Tzirogiannis K.N., Panoutsopoulos G.I., Demonakou M.D., Hereti R.I., Alexandropoulou K.N., Basayannis A.C., Mykoniatis M.G. Time-course of cadmium-induced acute hepatotoxicity in the rat liver: the role of apoptosis. Arch. Toxicol. 2003, 77:694-701.
50. Wang T., Shankar K., Ronis M.J., Mehendale H.M. Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes. Crit. Rev. Toxicol. 2007, 37:413-459.
51. Yannaki E., Athanasiou E., Xagorari A., Constantinou V., Batsis I., Kaloyannidis P., Proya E., Anagnostopoulos A., Fassas A. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp. Hematol. 2005, 33:108-119.